Clinical Report: Texas Practice Resolves Controlled Substances Act Allegations
Overview
Total MD Physicians Group and Dr. Mason Jones have settled allegations of Controlled Substances Act violations, agreeing to pay up to $600,000. The allegations included deficiencies in record-keeping and improper electronic issuance of prescriptions without a physician-patient relationship.
Background
The Controlled Substances Act (CSA) regulates the prescription of controlled substances to prevent misuse and ensure patient safety. Violations of the CSA can lead to legal and financial repercussions for healthcare providers.
Data Highlights
No numerical data or trial data available in the source material.
Key Findings
- Total MD Physicians Group and Dr. Mason Jones reached a civil settlement of up to $600,000.
- Allegations included deficiencies in record-keeping and electronic prescription issuance.
- The US Drug Enforcement Administration identified violations during inspections in 2023.
- The settlement resolves allegations but does not determine liability.
- Reckless prescribing practices can endanger public health and undermine the medical profession.
Clinical Implications
Healthcare providers must ensure compliance with the CSA.
Conclusion
The settlement resolves allegations but does not determine liability.
Related Resources & Content
- US Drug Enforcement Administration, US Department of Justice, 2023 -- Texas Practice Resolves Controlled Substances Act Allegations
- MDSpire News — Psychiatrist Settles False Claims, Controlled Substances Allegations
- MDSpire News — Settlement Bars Two From DEA Registration
- Associated Press Health — Paxton sues another provider accused of illegally sending abortion-inducing pills to Texans
- MDSpire News — Inside Access, Outside the Rules
- Psychiatrist Settles False Claims, Controlled Substances Allegations
- Settlement Bars Two From DEA Registration
- Paxton sues another provider accused of illegally sending abortion-inducing pills to Texans
- https://www.govinfo.gov/content/pkg/CFR-2023-title21-vol9/pdf/CFR-2023-title21-vol9-part1311.pdf
- 21 CFR 1304.04 | Maintenance of records and… | eCFR.io
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 | MMWR
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
